CS logo
small CS logo
Imam Khomeini Hospital

Tehran, Iran, Islamic Republic of
1,300 Beds

About Imam Khomeini Hospital


Imam Khomeini Hospital or also Hezar Takhtkhabi Hospital Center is a teaching hospital complex and biomedical research facility of Tehran University of Medical Sciences, located in Tehran, Iran.
There are 1,300 beds in Imam Khomeini Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Imam Khomeini Hospital


During the past decade, Imam Khomeini Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Imam Khomeini Hospital" #1 collaborator was "Pars No Tarkib Co" with 1 trials as a collaborator and "RojanPharma Pharmaceutical Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Imam Khomeini Hospital


According to Clinical.Site data, the most researched conditions in "Imam Khomeini Hospital" are "Cervix Uteri Cancer" (1 trials), "Coronavirus Disease 2019" (1 trials), "Covid-19" (1 trials), "Covid19" (1 trials) and "Emergencies" (1 trials). Many other conditions were trialed in "Imam Khomeini Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Imam Khomeini Hospital


Most popular intervention types in "Imam Khomeini Hospital" are "Drug" (11 trials), "Other" (3 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Fentanyl" (2 trials), "Midazolam" (2 trials), "Bevacizumab + FOLFIRI-3" (1 trials), "Botulinum Toxin A" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Imam Khomeini Hospital


The vast majority of trials in "Imam Khomeini Hospital" are 15 trials for "All" genders and 3 trials for "Female" genders.

Clinical Trials Status at Imam Khomeini Hospital


Currently, there are NaN active trials in "Imam Khomeini Hospital". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Imam Khomeini Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Imam Khomeini Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".